Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].

Przeglad epidemiologiczny - 1 Jan 2011

Prygiel Marta, Janaszek-Seydlitz Wiesława, Bucholc Bozena

Abstract excerpt

All vaccines against tuberculosis used actually over the world contain Mycobacterium bovis BCG strains (Bacillus Calmette-Guerin) as active substance. Strain BCG, that was obtained in 1921 by Calmette and Guerin after 13 years ofpassaging on the potato-glicerol medium with addition of bile, was distributed to many laboratories for vaccine production. The repeated passages of M. bovis BCG strain in different...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BCG Vaccine
Share to DNA, Bacterial
Share to Genes, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Bacterial

Share to Mycobacterium bovis

Share to Mycobacterium tuberculosis

Share to Species Specificity

Share to Tuberculosis

Source

Identifiers

PMID: 22390050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].PMID 22390050Read ↗

Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Guérin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains.Semantic proximity Read ↗

Crucial requirement for standardization during the development of novel recombinant BCG vaccines: Does the corresponding substrain background matter?Semantic proximity Read ↗

Manipulation of BCG vaccine: a double-edged swordSemantic proximity Read ↗

Genome Sequencing and Analysis of BCG Vaccine StrainsSemantic proximity Read ↗

BCG--different strains, different vaccines?Semantic proximity Read ↗

[Search for new tuberculosis vaccines].Semantic proximity Read ↗

Genomic characteristics of two most widely used BCG vaccine strains: Danish 1331 and Pasteur 1173P2Semantic proximity Read ↗

BCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacySemantic proximity Read ↗

BCG VaccinesSemantic proximity Read ↗

Bacillus Calmette–Guérin strain differences as the basis for immunotherapies against bladder cancerSemantic proximity Read ↗

Recombinant BCG: innovations on an old vaccine. Scope of BCG strains and strategies to improve long-lasting memorySemantic proximity Read ↗

Correlation between BCG genomics and protective efficacy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.